- Home
- ARDX vs CET Comparison
ARDX vs CET Comparison
Compare ARDX & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- CET
- Stock Information
- Founded
- ARDX 2007
- CET 1929
- Country
- ARDX United States
- CET United States
- Employees
- ARDX N/A
- CET N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- CET Finance/Investors Services
- Sector
- ARDX Health Care
- CET Finance
- Exchange
- ARDX Nasdaq
- CET Nasdaq
- Market Cap
- ARDX 1.4B
- CET 1.3B
- IPO Year
- ARDX 2014
- CET N/A
- Fundamental
- Price
- ARDX $5.06
- CET $47.34
- Analyst Decision
- ARDX Buy
- CET
- Analyst Count
- ARDX 8
- CET 0
- Target Price
- ARDX $9.93
- CET N/A
- AVG Volume (30 Days)
- ARDX 3.6M
- CET 18.8K
- Earning Date
- ARDX 02-20-2025
- CET 01-01-0001
- Dividend Yield
- ARDX N/A
- CET 4.76%
- EPS Growth
- ARDX N/A
- CET 26.33
- EPS
- ARDX N/A
- CET 9.95
- Revenue
- ARDX $333,615,000.00
- CET $23,698,535.00
- Revenue This Year
- ARDX $169.30
- CET N/A
- Revenue Next Year
- ARDX $14.87
- CET N/A
- P/E Ratio
- ARDX N/A
- CET $4.75
- Revenue Growth
- ARDX 168.06
- CET 11.75
- 52 Week Low
- ARDX $4.32
- CET $38.40
- 52 Week High
- ARDX $9.83
- CET $49.51
- Technical
- Relative Strength Index (RSI)
- ARDX 41.70
- CET 49.08
- Support Level
- ARDX $5.37
- CET $47.78
- Resistance Level
- ARDX $6.55
- CET $48.40
- Average True Range (ATR)
- ARDX 0.31
- CET 0.42
- MACD
- ARDX -0.02
- CET -0.06
- Stochastic Oscillator
- ARDX 0.67
- CET 20.28
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.